70.22.Z - Business and other management consultancy activities
21.20.Z - Manufacture of medicines and other pharmaceutical products
27.90.Z - Manufacture of other electrical equipment
32.50.Z - Manufacture of medical and dental instruments and supplies
38.22.Z - Hazardous waste processing and neutralizing
62.01.Z - Computer programming activities
69.10.Z - Legal activities
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -1,3 | 6,5 | -6,2 | -195,4 |
EBITDA | -0 | |||
Short time liabilities | 19,9 | |||
Income tax | 0 | 0 | 0 | |
Equity capital | 2,1 | 8,6 | 2,4 | -71,9 |
Operating profit (EBIT) | -1,3 | |||
Assets | 22 | 13,7 | 14,2 | 3,6 |
Net profit (loss) | -1,3 | 6,5 | -6,2 | -195,4 |
Cash | 7,5 | |||
Net income from sale | 136,3 | |||
Liabilities and provisions for liabilities | 19,9 | 5,1 | 11,8 | 129,6 |
Working assets | 22 | 13,7 | 14,2 | 3,6 |
Basic operational activity income | 273,6 | 0 | -100 | |
Depreciation | 1,3 | |||
% | % | % | p.p. | |
Profitability of capital | -60 | 75,4 | -256,3 | -331,7 |
Equity capital to total assets | 9,6 | 62,5 | 16,9 | -45,6 |
Gross profit margin | -0,9 | 2,4 | 3,3 | |
EBITDA Margin | -0 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 53 | |||
Current financial liquidity indicator | 1.105949878692627 | |||
Net dept to EBITDA | 355.3713684082031 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane